Who
Aby J. Mathew
EVP & Chief Scientific Officer
Company insider
Files Form 4 as: EVP & Chief Scientific Officer, BioLife Solutions.
In numbers
- Trades disclosed
- 332
- Buys
- 1
- Sells
- 136
- Bought
- $20K
- Sold
- $20.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Apr 2014
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —45,838 | filing |
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —40,192 | filing |
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $2.7M70,000 at $38.61 | filing |
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code D | —404,608 | filing |
| 18 Sep 2026filed 22 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $21K564 at $36.69 | filing |
| 18 Sep 2026filed 22 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $21K564 at $36.69 | filing |
| 8 Sep 2026filed 10 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $22K627 at $35.38 | filing |
| 8 Sep 2026filed 10 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $22K627 at $35.38 | filing |
| 7 Jul 2026filed 13 Jul 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $14K516 at $27.79 | filing |
| 7 Jul 2026filed 13 Jul 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $14K516 at $27.79 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $15K564 at $26.04 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $15K564 at $26.04 | filing |
| 8 Jun 2026filed 10 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $16K627 at $26.10 | filing |
| 8 Jun 2026filed 10 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $16K627 at $26.10 | filing |
| 8 Apr 2026filed 10 Apr 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $9,924515 at $19.27 | filing |
| 8 Apr 2026filed 10 Apr 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $9,924515 at $19.27 | filing |
| 19 Mar 2026filed 23 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $43K2,255 at $19.12 | filing |
| 19 Mar 2026filed 23 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $43K2,255 at $19.12 | filing |
| 3 Mar 2026filed 5 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $11K529 at $20.74 | filing |
| 3 Mar 2026filed 5 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $11K529 at $20.74 | filing |
News
No headline names them, or the companies they trade most, lately.